PubRank
Search
About
Thorbald van Hall
Author PubWeight™ 35.19
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4+ Th1 cells.
J Immunol
2011
2.02
2
Peptide vaccination after T-cell transfer causes massive clonal expansion, tumor eradication, and manageable cytokine storm.
Cancer Res
2010
1.59
3
DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.
Cancer Res
2007
1.45
4
Design of agonistic altered peptides for the robust induction of CTL directed towards H-2Db in complex with the melanoma-associated epitope gp100.
Cancer Res
2009
1.26
5
Activation of tumor-promoting type 2 macrophages by EGFR-targeting antibody cetuximab.
Clin Cancer Res
2011
1.24
6
Antigen storage compartments in mature dendritic cells facilitate prolonged cytotoxic T lymphocyte cross-priming capacity.
Proc Natl Acad Sci U S A
2009
1.24
7
Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes.
Nat Immunol
2010
1.24
8
Distinct uptake mechanisms but similar intracellular processing of two different toll-like receptor ligand-peptide conjugates in dendritic cells.
J Biol Chem
2007
1.23
9
Therapeutic cancer vaccines.
J Clin Invest
2015
1.23
10
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8⁺ T lymphocytes.
Proc Natl Acad Sci U S A
2011
1.17
11
In aged mice, outgrowth of intraocular melanoma depends on proangiogenic M2-type macrophages.
J Immunol
2010
1.15
12
Anti-inflammatory M2 type macrophages characterize metastasized and tyrosine kinase inhibitor-treated gastrointestinal stromal tumors.
Int J Cancer
2010
1.06
13
The nonpolymorphic MHC Qa-1b mediates CD8+ T cell surveillance of antigen-processing defects.
J Exp Med
2009
1.05
14
Strategies to counteract MHC-I defects in tumors.
Curr Opin Immunol
2011
1.02
15
Prospects of combinatorial synthetic peptide vaccine-based immunotherapy against cancer.
Semin Immunol
2013
0.96
16
Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2.
Mol Immunol
2012
0.94
17
Dendritic cells process synthetic long peptides better than whole protein, improving antigen presentation and T-cell activation.
Eur J Immunol
2013
0.93
18
Expression of a natural tumor antigen by thymic epithelial cells impairs the tumor-protective CD4+ T-cell repertoire.
Cancer Res
2005
0.92
19
Inhibition of mouse TAP by immune evasion molecules encoded by non-murine herpesviruses.
Mol Immunol
2011
0.89
20
Characterization of antigen-specific immune responses induced by canarypox virus vaccines.
J Immunol
2007
0.88
21
CD8+ T cell responses against TAP-inhibited cells are readily detected in the human population.
J Immunol
2010
0.86
22
Effective cooperation of monoclonal antibody and peptide vaccine for the treatment of mouse melanoma.
J Immunol
2012
0.85
23
TAP-independent self-peptides enhance T cell recognition of immune-escaped tumors.
J Clin Invest
2016
0.85
24
Proline substitution independently enhances H-2D(b) complex stabilization and TCR recognition of melanoma-associated peptides.
Eur J Immunol
2013
0.84
25
Different expression levels of the TAP peptide transporter lead to recognition of different antigenic peptides by tumor-specific CTL.
J Immunol
2011
0.83
26
Peptide transporter TAP mediates between competing antigen sources generating distinct surface MHC class I peptide repertoires.
Eur J Immunol
2011
0.83
27
Evidence for natural killer cell-mediated protection from metastasis formation in uveal melanoma patients.
Invest Ophthalmol Vis Sci
2009
0.82
28
New role of signal peptide peptidase to liberate C-terminal peptides for MHC class I presentation.
J Immunol
2013
0.82
29
Promiscuous binding of invariant chain-derived CLIP peptide to distinct HLA-I molecules revealed in leukemic cells.
PLoS One
2012
0.81
30
Importance of TAP-independent processing pathways.
Mol Immunol
2012
0.81
31
Targeting host B-cell immune responses by persistent donor NK-cell alloreactivity following nonmyeloablative allogeneic stem cell transplantation.
Blood
2007
0.81
32
Effective immunotherapy of cancer in MUC1-transgenic mice using clonal cytotoxic T lymphocytes directed against an immunodominant MUC1 epitope.
J Immunother
2002
0.79
33
Application of multicolor fluorescence in situ hybridization analysis for detection of cross-contamination and in vitro progression in commonly used murine tumor cell lines.
Cancer Genet Cytogenet
2002
0.78
34
Infiltrating CTLs are bothered by HLA-E on tumors.
Oncoimmunology
2012
0.78
35
Induction of protective CTL immunity against peptide transporter TAP-deficient tumors through dendritic cell vaccination.
Cancer Res
2007
0.77